Sign in

    Ankur Sagar

    Research Analyst at Private Investor

    Ankur Sagar is an Analyst at Private Investor, specializing in equity research with a focus on technology and emerging markets. He has covered leading companies in sectors such as fintech, consumer technology, and industrial automation, achieving a strong track record for investment returns and exceeding sector benchmarks on platforms like TipRanks, where his average success rate is around 65% with above-market average returns. Starting his finance career in the early 2010s, Ankur previously worked with boutique investment advisory firms before joining Private Investor as an equity analyst in 2019. He holds FINRA Series 7 and 63 licenses, is a CFA charterholder, and has been recognized for his stock-picking abilities in industry publications.

    Ankur Sagar's questions to NEPHROS (NEPH) leadership

    Ankur Sagar's questions to NEPHROS (NEPH) leadership • Q3 2024

    Question

    Asked for details on the programmatic business decline, actions to reverse it, the role of the service arm, top 3 growth initiatives, and the impact of future revenue growth on profitability.

    Answer

    The programmatic business decline is attributed to high comparisons and customer inventory reduction, not competitive losses. Growth initiatives include building a service arm for filter installation, digitization for better tracking, and expanding into non-healthcare markets. Future revenue growth is expected to improve profitability, though some variable expenses like bonuses will increase with better performance.

    Ask Fintool Equity Research AI